Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Astrazeneca cancels £450m vaccine plant, blaming state funding cut
AstraZeneca has cancelled a £450m investment in a manufacturing plant, saying Labour have failed to match the previous government’s funding.
AstraZeneca ditches plan to build $558 mln UK vaccine plant
AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.
AstraZeneca abandons plan for £450m vaccine plant in UK
In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in the UK, after the government reduced the offer on the table to support the project.
AstraZeneca Calls Off Vaccine Hub Investment Over UK Funding
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding for the site.
Rachel Reeves dealt blow with AstraZeneca axing £450m vaccine plant plans
AstraZeneca has axed plans to build a £450million vaccine manufacturing plant because of a lack of Government support in the latest blow to Rachel Reeves. The Labour government last summer tried to reduce the amount of state support provided to the Liverpool project from about £90million to £40million,
13m
on MSN
AstraZeneca ditches UK investment over cut in government support
AstraZeneca will no longer invest 450 million pounds ($558.3 million) at its vaccine manufacturing plant in northern England, ...
ジャパンタイムズ
2h
AstraZeneca and Daiichi’s breast cancer drug gets EU backing
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...
1h
on MSN
AstraZeneca, Daiichi win EU backing for breast cancer drug Dato-DXd
AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...
35m
on MSN
AstraZeneca cancels £450m investment in UK after dispute over Government support
AstraZeneca cancels £450m investment in UK after dispute over Government support - The pharmaceutical giant claimed the ...
FierceBiotech
21h
AstraZeneca antibody protects macaques from severe bird flu, suggesting prophylactic potential in case of outbreak
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
7d
AstraZeneca To Pump $570 Million Into Canada, Driving Expansion, Job Growth
AstraZeneca invests $570 million in Canada, expands facilities, and boosts R&D efforts, aiming to deliver 20 new medicines ...
1d
Guggenheim Sticks to Their Buy Rating for AstraZeneca (AZN)
In a report released yesterday, Seamus Fernandez from Guggenheim reiterated a Buy rating on AstraZeneca (AZN – Research Report), with a price ...
13m
AstraZeneca cancels £450m UK investment after dispute over Government support
Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government’s proposal' ...
BioPharma Dive
1d
Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
United States
Enhertu
Philippines
Daiichi Sankyo
Food and Drug Administration
Feedback